Skip to main content

J&J CEO Testifies In NJ Court Over Talcum Powder Trial

J&J CEO Testifies In NJ Court Over Talcum Powder Trial

J&J CEO Testifies In NJ Court Over Talcum Powder Trial

Introduction

Johnson & Johnson's Chief Executive Officer Alex Gorsky was called for the first time in the court, to testify in the lawsuit of the company's baby powder, causing cancer.

The lawsuit filed at a state courtroom in New Brunswick, New Jersey, near the company’s headquarters included three men and one woman. According to the lawsuit, all four plaintiffs are suffering from mesothelioma, a rare and incurable cancer. All four plaintiffs claim that they contracted cancer due to their exposure to asbestos in baby powder, which was applied when they were infants.

The jury held J&J liable for the plaintiffs’ cancers and awarded them $37.2 million in compensation in the early phase of the trial. Now the lawyers for plaintiffs are seeking to persuade a second jury claiming that punitive damages are necessary for the reckless behavior of J&J.

Gorsky testified that he was not aware of the safety measures of the powder as the issue can be traced back in 2012 before he joined the company. The attorneys for J&J responded to the statement by saying that they will look into the issue, which might result in dragging the previous executives to the court.

Currently, J&J faces 16,000 lawsuits against their baby powder. Lawsuits claim that the company failed to warn users about the contamination of powder because of asbestos.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!